Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/MGRX/Shareholders’ equity

Mangoceuticals, Inc. (MGRX) Shareholders’ equity 2022–2025

Mangoceuticals, Inc. (MGRX) shareholders’ equity at each fiscal year-end, per SEC filings.

$15.2MFY2025 · since FY2022: $614,030 → $15.2M
22232425
Fiscal yearValueYoY
FY2025$15.2M+9.0%
FY2024$13.9M+1700.1%
FY2023$774,754+26.2%
FY2022$614,030—

Source: SEC XBRL filings · For reference only · Not investment advice

More MGRX financial trends

MGRX RevenueMGRX Net incomeMGRX Net marginMGRX Gross profitMGRX Gross marginMGRX Operating incomeMGRX Operating marginMGRX Operating cash flowMGRX Free cash flowMGRX Capital expendituresMGRX Return on equityMGRX Stock buybacksMGRX Dividends paidMGRX Total assetsMGRX Total liabilitiesMGRX overview →